AbbVie Reports First-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
AbbVie (ABBV) Tops Q1 EPS by 17c, Confirms FY EPS Guidance
May 1, 2020 7:45 AM EDTAbbVie (NYSE: ABBV) reported Q1 EPS of $2.42, $0.17 better than the analyst estimate of $2.25. Revenue for the quarter came in at $8.62 billion versus the consensus estimate of $8.33 billion.
GUIDANCE:
AbbVie sees FY2020 EPS of $9.61-$9.71, versus the consensus of... More
